In 2009, the U.S. Food and Drug Administration advised consumers to discontinue use of Hydroxycut due to the serious liver injuries associated to with the product. The manufacturers of Hydroxycut, Lovate Health Science, complied with the warning and removed the product from the market.
The FDA received reports of one liver failure death and a number of liver-related health problems associated with the use of Hydroxycut. There have also been reports of cardiovascular disorders and muscle damage connected to kidney failure related to the product. The health issues were reported by users using the recommended dosage. The FDA states that while the adverse effects are rare, the product presents an undue risk to the consumer.